Skills this job asks for
LeadershipInventory managementTranslation
Add your CV (free) to see which of these your CV is missing.
Sponsorship verdict
Sponsorship possible
One solid signal, not two. Worth applying, and worth asking about sponsorship early.
-
✓
Employer is on a government sponsor recordThe US Department of Labor certified 159 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first.
-
?
The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
-
?
No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area.
-
✓
What Gilead Sciences INC paid sponsored hires in similar roles2 certified filings for “Associate Director, Patient Safety” (Medical and Health Services Managers) in CA: $209k–$226k, median $217k.
-
✓
Confirmed live todayWhen a source last listed this job as open.
Details and sources
- Employer is on a government sponsor record
- The US Department of Labor certified 159 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. Source: LCA disclosure data (US Department of Labor (OFLC)).
- No salary bar for this route
- H-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Gilead Sciences INC paid sponsored hires in similar roles
- 2 certified filings for “Associate Director, Patient Safety” (Medical and Health Services Managers) in CA: $209k–$226k, median $217k. Most were filed at wage level IV (100%) — 4 lottery entries, ≈61% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence. It is not legal advice and never a guarantee: the employer and the immigration authority decide. Sign in to factor in where you can already work.
About the role
At Gilead, we’re creating a healthier world for all people. For more than 35 years, we’ve tackled diseases such as HIV, viral hepatitis, COVID-19 and cancer – working relentlessly to develop therapies that help improve lives and to ensure access to these therapies across the globe. We continue to fight against the world’s biggest health challenges, and our mission requires collaboration, determination and a relentless drive to make a difference.
Every member of Gilead’s team plays a critical role in the discovery and development of life-changing scientific innovations. Our employees are our greatest asset as we work to achieve our bold ambitions, and we’re looking for the next wave of passionate and ambitious people ready to make a direct impact.
We believe every employee deserves a great leader. People Leaders are the cornerstone to the employee experience at Gilead and Kite. As a people leader now or in the future, you are the key driver in evolving our culture and creating an environment where every employee feels included, developed and empowered to fulfil their aspirations. Join Gilead and help create possible, together.
Job Description
At Gilead our pursuit of a healthier world for all people has yielded a cure for hepatitis C, revolutionary improvements in HIV treatment and prevention as well as advancements in therapies for viral and inflammatory diseases and certain cancers.
We set and achieve bold ambitions in our fight against the world’s most devastating diseases, united in our commitment to confronting the largest public health challenges of our day and improving the lives of patients for generations to come. As the Director, US Medical Affairs, Liver Strategy, at Gilead you are a critical strategic and operational leader responsible for shaping and driving the overarching USMA Liver strategy for healthcare professional (HCP) engagement and medical education across PBC and HDV.
The Director will help to create and translate enterprise medical strategy into integrated USMA Liver materials, tactics, and external scientific communications, ensuring a consistent, compliant, and high-impact medical voice in the U.S.
Essential Duties and Responsibilities:
• Lead development of overarching USMA Liver strategy for HCP engagement, scientific exchange, and medical education across PBC and HDV, aligned with enterprise priorities and evidence plans.
• Translate USMA Liver strategy into executable medical tactics, including field-facing materials, scientific narratives, congress strategies, symposia content, advisory boards, and digital engagement approaches.
• Serve as a senior Medical Affairs thought partner to Field Medical leadership, ensuring resources are field-ready, impactful, and aligned to priority HCP and KOL audiences.
• Own end-to-end medical resource and content operations for USMA Liver: oversee internal and external (agency) development, timelines, version control, and quality standards.
• Lead U.S. Medical Review Committee (MRC) governance for Liver materials, including preparation, submission, facilitation of review discussions, incorporation of feedback, and driving materials to approval.
• Ensure pull-through and appropriate adaptation of Global medical content for U.S. use, and oversee development of original U.S.-specific liver medical materials.
• Operationalize approved resources by coordinating training, launch, distribution, and adoption across field medical, digital platforms (e.g., CLM/MedDocs), and cross-functional teams.
• Maintain lifecycle management of liver medical assets, including renewals, expirations, proactive updates, and inventory of live materials.
• Lead HDV tactical planning and execution, including Annual Encore planning, congress deliverables, and ad hoc initiative
Apply on employer site ↗